Specific Modified Exercise Program for Patients Having Chronic Asthma

NCT ID: NCT06197737

Last Updated: 2024-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

78 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-01

Study Completion Date

2024-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the effects of moderate intensity interval training and sprint interval training on patients having chronic asthma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic asthma is a complex heterogeneous disease characterized by multiple aggravating factors. Asthma is treated with two types of medicines , long term medicines and quick relieve medicine. Although the relationship between asthma and the effects of HIIT/SIT were studied in the literature, there was not one comparing the results of these aforementioned studies. The purpose of this study is to find the effects of moderate intensity interval training and sprint interval training on pat determine effects of group wise physical activity on asthma related quality of life. To determine the effects of group wise physical activity on cardiorespiratory endurance

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Moderate Intensity Interval Training

These participants will perform moderate intensity interval training. The intervention will be applied thrice a week. Moderate intensity interval training in which they do stair climbing 3 times a week And for every 1 interval I will ask them to take rest for 3 minutes.

Group Type EXPERIMENTAL

Moderate Intensity Interval Training

Intervention Type OTHER

Participants in this group will perform moderate intensity interval training in which they will perform stair climbing 3 times a week and for every 1 interval I will ask them to take rest for 3 minutes.

Sprint Interval Training

These participants will perform sprint interval training and frequency will be 3 days a week.

The participants will perform sprint interval training in which they will do stair climbing 3 times a week with a fast pace.

Group Type EXPERIMENTAL

Sprint Interval Training

Intervention Type OTHER

sprint interval training in which they will do stair climbing 3 times a week with a fast pace.

pharmacological treatment

They will be on pharmacological treatment as prescribed by their pulmonologist.

Group Type OTHER

pharmacological treatment

Intervention Type OTHER

They will be on pharmacological treatment as prescribed by their pulmonologist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Moderate Intensity Interval Training

Participants in this group will perform moderate intensity interval training in which they will perform stair climbing 3 times a week and for every 1 interval I will ask them to take rest for 3 minutes.

Intervention Type OTHER

Sprint Interval Training

sprint interval training in which they will do stair climbing 3 times a week with a fast pace.

Intervention Type OTHER

pharmacological treatment

They will be on pharmacological treatment as prescribed by their pulmonologist.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients having chronic asthma
* Age between 15-25 years.
* Participants having no dyspnea at rest .
* Participants scoring 13 or less on borg scale

Exclusion Criteria

* History of co-morbidities.
* History of recent fractures.
* Participants scoring greater than 13 on BORG scale


* Exercise induced asthma (evaluated through BRUCE protocol).
* Individuals with co-morbidities related to any neurological, cardiovascular, psychological and musculoskeletal disorders .
* Patients score falling 15 or more on Borg scale.
Minimum Eligible Age

15 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Malik Muhammad Ali Awan, MSPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Abasyn University

Islamabad, Federal Capital, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/MS-PT/01379

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.